Intimation of Closure of Trading Window under Regulation 30 of SEBI LODR Regulations, 2015 for the Quarter ended June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals has informed the stock exchanges that the trading window for dealing in the company's shares will remain closed for designated persons (directors, KMP, auditors, employees, and their immediate relatives) until 48 hours after the announcement of unaudited financial results for the quarter ended June 30, 2025. This is a routine compliance filing under Regulation 30 of SEBI LODR Regulations, 2015, aimed at preventing insider trading during the results announcement period. No financial figures, business updates, or material events are disclosed in this intimation. The closure typically begins a few days before the end of the quarter and extends until results are made public.
This is a standard regulatory compliance announcement with no material impact on the stock or shareholders. Investors should await the upcoming Q1 FY2026 results for any meaningful business or financial updates.